vitamin d- ergocalciferol capsule
preferred pharmaceuticals, inc. - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d- ergocalciferol capsule
bryant ranch prepack - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
ergocalciferol - vitamin d2 oral drops
vitamin d2 - oral drops - 10,000 iu - ergocalciferol
doxercalciferol capsule
west-ward pharmaceuticals corp. - doxercalciferol (unii: 3diz9lf5y9) (doxercalciferol - unii:3diz9lf5y9) - doxercalciferol 0.5 ug - doxercalciferol capsules is contraindicated in patients with: risk summary: the limited available data with doxercalciferol in pregnant women are insufficient to identify a drug-associated risk for major birth defects, miscarriage or adverse maternal or fetal outcomes. there are risks to the mother and fetus associated with chronic kidney disease in pregnancy [see clinical considerations ]. in reproduction studies in rats and rabbits administered doxercalciferol during organogenesis at up to 20 mcg/kg/day and 0.1 mcg/kg/day, respectively (approximately 25 times (rats) and less than (rabbits) the maximum recommended human oral dose of 60 mcg/week based on mcg/m2 body surface area), no adverse developmental effects were observed [see data ]. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2% to 4% and 15% to 20
ergocalciferol capsule, liquid filled
sigmapharm laboratories, llc - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp, are a synthetic calcium regulator for oral administration. ergocalciferol is a white, colorless crystal, insoluble in water, soluble in organic solvents, and slightly soluble in vegetable oils. it is affected by air and by light. ergosterol or provitamin d2 is found in plants and yeast and has no antirachitic activity. there are more than 10 substances belonging to a group of steroid compounds, classified as having vitamin d or antirachitic activity. one usp unit of vitamin d2 is equivalent to one international unit (iu), and 1 mcg of vitamin d2 is equal to 40 iu. each capsule contains 1.25 mg (50,000 international units vitamin d) of ergocalciferol, usp, in an edible vegetable oil. ergocalciferol, also called vitamin d2, is 9, 10-secoergosta-5, 7, 10 (19), 22-tetraen-3-ol,(3β,5z,7e,22e)-; (c28h44o) with a molecular weight of 396.65, and has the following structural formula:
vitamin d- ergocalciferol capsule
bryant ranch prepack - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.
vitamin d2 and k1- ergocalciferol, phytonadione liquid
puretek corporation - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc), phytonadione (unii: a034se7857) (phytonadione - unii:a034se7857) -
troy vitamin ade injection for cattle, sheep & pigs
troy laboratories pty ltd - retinol as the palmitate; vitamin d3 = cholecalciferol; alpha tocopherol acetate (vitamin e) as vitamin e adsorb - parenteral liquid/solution/suspension - retinol as the palmitate vitamin-a active 500000.0 iu/ml; vitamin d3 = cholecalciferol vitamin-d3 active 50000.0 iu/ml; alpha tocopherol acetate (vitamin e) as vitamin e adsorb vitamin-e active 50.0 mg - nutrition & metabolism - cattle | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | heifer | steer - vitamin a deficiency | vitamin d deficiency | vitamin e deficiency
multivitamin solution for injection
norbrook laboratories limited - vitamin a palmitate ; vitamin d3 ; vitamin e acetate ; thiamine hydrochloride ; riboflavin sodium phosphate ; pyridoxine hydrochloride; nicotinamide; dexpanthenol; cyanocobalamin - solution for injection - . - vitamin b-complex, incl. combinations - cattle, pigs, sheep - vitamins and minerals
nov-a-vit 500 formulation: each ml contains: retinol propionate (vitamin a) (equivalent to 500,000 iu)...................200 mg alpha-tocopherol acetate (vitamin e) (equivalent to 75,000 iu) ........... 50 mg cholecalciferol (vitamin d3) (equivalent to 50 iu).....1.875 mg emulsion for injection (im)
rnsv corporation; distributor: rnsv corporation - retinol propionate (vitamin a) , cholecalciferol (vitamin d3) , alpha-tocopherol acetate (vitamin e) (vet.) - emulsion for injection (im) - formulation: each ml contains: retinol propionate (vitamin a) (equivalent to 500,000 iu)...................200 mg alpha-tocopherol acetate (vitamin e) (equivalent to 75,000 iu) ........... 50 mg cholecalciferol (vitamin d3) (equivalent to 50 iu).....1.875 mg